|
Testosterone is Your Friend
Download This Book
|
Chapter 10: Testosterone and Your Prostate ______________________________________________________
The medical profession has an unquestioned “Huggins” dogma that testosterone is somehow “bad” for the male prostate gland. When prostate cancer patients are castrated they very temporarily (emphasis on the temporary part) improve, but their cancer then grows with a vengeance. This is Sacred Dogma, and anyone who questions it is condemned as a heretic or worse. Common sense tells you nothing gets better when you cut a man’s testicles off - whether you use a scalpel or prescription drugs like Lupron® and Casodex®. Doctors still literally castrate men physically believe it or not. Talk about the Dark Ages!
You can see clearly from the Male Estrogen and Testo-sterone Chart (pp. 58) that, as men age, their estrogen rises while their testosterone falls. Young men with naturally high testosterone (and low estrogen) levels are almost completely immune to prostate disease. The fall in testosterone and rise is estrogen - the reversal of the testosterone to estrogen ratio - almost exactly pa-rallels the rise in prostate disease of all kinds. As testosterone falls, BPH, prostatitis and prostate cancer all rise accordingly. The more youthful the testosterone level the healthier men will be in all ways.
The worldwide published clinical studies on testosterone levels and prostate health prove unequivocally beyond any doubt whatsoever that testosterone is necessary for good prostate health and metabolism. The higher the testosterone levels the lower the rates of prostate disease. The lower the testosterone levels the higher the rates of prostate disease. When men are low in testo-sterone the prostate receptors must accept dihydrotestosterone (DHT) instead of the real thing. Studies show that prostate disease is largely due to the gland having an inordinate amount of DHT bound to it rather than real testosterone. Youthful levels of all the androgens including DHEA and androstenedione are important to good prostate health. We are going to list a partial (18 out of 70) and very abbreviated condensation of the chapter “Testosterone Is Your Friend” from my book The Natural Prostate Cure. Please see the book for all 70 of the complete studies.
All the way back in 1936 at Oxford University in England (Proceedings of the Royal Society of Medicine) doctors realized that the “male hormone” was necessary for good prostate health and the “female hormone” was bad for prostate health. Testo-sterone had only first been synthesized in 1935 - a year earlier.
Almost seventy years ago in 1938 doctors at Louisiana State University (Journal of Urology) also knew that testosterone is good for prostate health. They realized how vital this hormone is, and that male health suffered as their levels fell during normal aging. They saw great promise in supplemental testosterone now that it was synthesized and could be given to aging men.
At the University of Washington (Cancer Research, v. 59, 1999, pp.4161-4) a progressive, innovative and free thinking doctor named Richmond Prehn actually said that we should consider giving androgen supplements to reduce the growth of prostate cancer! You don’t know how much courage it took to say that, or for the journal Cancer Research to print it. He showed that earlier studies proved low testosterone levels led to a far worse prognosis than in men with higher testosterone levels. Doctors like this are leading us into the Age of Enlightenment.
At the University of Witwaterstrand in South Africa (American Journal of Clinical Oncology, v. 20, 1997, pp. 605-8) 122 men with prostate cancer were studied for their testosterone levels, “Low Serum Testosterone Predicts a Poor Outcome in Metastatic Prostate Cancer”. The men with the highest levels of testosterone had the least aggressive tumors and lived the longest. The men with the lowest levels had the most aggressive tumors and died quickly. They concluded, “Low testosterone seems to result in a more aggressive disease and a poorer prognosis in advanced prostate cancer.”
At Hubei Medical University in China (Hubei Yike Daxue Xeubao, v. 19, 1998, pp. 241-2) doctors studied men with BPH and outright prostate cancer. They found, “The results showed that serum testosterone in patients with BPH and PCA (cancer) was lower than that of the (healthy) control group.” They said further, “…the ratio of testosterone to estradiol is decreased with the rise of the age. The results suggested that the imbalance of serum sex hormones (i.e. falling testosterone and rising estrogen) was related to the pathogenesis of BPH and PCA.” Pretty clear here, too.
At the world famous Harvard Medical School (Journal of Urology, v. 163, 2000, pp. 824-7) “Is Low Serum Testosterone a Marker for High Grade Prostate Cancer?” was published. Men with low testosterone levels had faster growing tumors, higher Gleason scores and died earlier. The conclusion was, “In our study patents with prostate cancer and a low free testosterone had more extensive disease. In addition, all men with a biopsy Gleason score of 8 or greater had low serum free testosterone. This finding suggests that low serum free testosterone may be a marker for more aggressive disease.”
At the University of Vienna (Prostate, v. 44, 2000, pp. 219-24) men with prostate cancer were compared to healthy controls. The men with cancer had decidedly lower testosterone levels than their healthy counterparts. Again we see the lower the testosterone the worse the diseases rates. They also found that youthful levels of the androgen DHEA was also necessary for good prostate health.
A second study at the University of Vienna (Journal of Urology, v. 169, 2003, pp. 1312-5) also studied men with prostate cancer. “Low serum testosterone in men with newly diagnosed prostate cancer is associated with higher tumor microvessels and androgen density (both of these factors promote cancer growth) as well as higher Gleason scores suggesting enhanced malignant potential.” As always testosterone is proven to be prostate healthy. A third study at the same university (Prostate, v. 47, 2001, pp. 52-8) found the same results with more patients. This was titled, “High Grade Prostate Cancer is Associated with Low Serum Testosterone Levels”. The title says it all. The men with low levels averaging only 2.8 ng/ml had the fastest growing malignancies and died faster. The men with high levels averaging 4.1 ng/ml had the slowest growing malignancies and lived the longest. Why aren’t we using testosterone supplements for prostate cancer?
At Harvard Medical School again (Journal of the American Medical Association v. 276, 1996, pp. 1904-6) prostate cancer patients fared better and lived longer the higher their testosterone level was. “A high prevalence of biopsy-detectable prostate cancer was identified in men with low total and free testosterone.” This is right from Harvard Medical School again folks. When will doctors start treating prostate disease with supplemental testosterone?
At the Memphis Veterans hospital (Journal of Urology, v. 144, 1989, pp. 1139-42) the military doctors found the elderly veterans with prostate cancer did much better the higher their testo-sterone levels. “Patients with a pretreatment level of testosterone less than 300 ng/ml had shorter intervals free of progression than patients with pretreatment levels greater than 300 ng/ml.” They referred to earlier studies that found exactly the same phenomenon. Testosterone should be used as therapy for prostate cancer.
A review done collectively by six international clinics (Cancer, Epidemiology, Biomarkers Preview, v. 6, 1997, pp. 967-9) used the Norwegian Cancer Registry to study the frozen blood serum and medical records of over 28,000 men. They found the higher the testosterone level the less prostate cancer and the longer their life. They concluded that the popular idea that testosterone promotes prostate cancer in any way is completely unsupported by the research. This is the second largest prostate cancer study in history and the results are simply inarguable based on 28,000 men.
At the University of Chicago and three other clinics (Journal of the American Medical Association, v. 265, 1991, pp. 618-21) more men with prostate cancer were studied. Divided into four groups of low to high testosterone each group clearly progressively thrived as their testosterone rating rose. The lowest group did the worst, while the highest group had the best quality of life, lived the longest, and their cancer grew the slowest.
At the famous Johns Hopkins Center in Baltimore (Prostate v. 27, 1995, pp. 25-31) healthy men were compared to those with BHP and prostate cancer. The healthy men had testosterone levels of 636 ng/ml, the men with BPH had 527, and the cancer patients only 473. The healthy men had a full one third higher testosterone levels than cancer patients - a very dramatic difference. Yet the doctors tried to deny their own data since it didn’t fit into their bias! “These data suggest there are no measurable differences in serum testosterone levels among men who are destined to develop prostate cancer and those without the disease”!!! How can there be “no measurable differences” between levels of 636 ng in healthy men and only 473 ng in cancer patients? This is the kind of blindness that keeps the medical profession perpetually in the dark.
At the University of Utah (Journal of Clinical Endo-crinology and Metabolism, v. 82, 1997, pp. 571-5) a very unusual study was done with 214 pairs of identical twins. Such rare studies are exceedingly accurate due to biological equality of the twins. They found the higher the testosterone the smaller the prostate glands, and the lower the testosterone the larger the prostate glands. “Prostate volume correlated inversely with age adjusted serum testosterone level.” This is inarguable proof youthful and higher testosterone levels promote good prostate health and help prevent disease.
At the Petrov Institute in Russia (International Journal of Andrology, v. 25, 2002, pp. 119-25) hypogonadal men averaging only 40 years old were given 80 or 120 mg of oral testosterone undecanoate salts depending on how low their testosterone was. After only six months their prostate volumes fell. They actually shrank their prostates giving them the wrong kind of testosterone in the wrong way. Imagine how much better they would have done with low doses of sublingual or transdermal testosterone. “These data suggest that exogenous testosterone in middle aged and older men with some clinical features of age-related testosterone deficiency can retard or even reverse prostate growth.”
At the Tenovus Institute in Wales (European Journal of Cancer, v. 20, 1984, pp. 477-82) 222 men with prostate cancer were studied. As usual they found the men with the lowest testosterone levels had the poorest prognosis and the earliest deaths. “Low concentrations of testosterone in plasma at the time of diagnosis related to a poor prognosis. Patients who died within one year of diagnosis had the lowest mean plasma levels of this steroid.” This study was done almost 20 years ago, yet doctors continue to castrate men both chemically and surgically.
The doctors at the University of Connecticut (Endocrine Research, v.26, 2000, pp. 153-68) gave elderly men both transdermal patches or unnatural injections of salts. Nearly all American men over 70 have prostate cancer even though most of them won’t actually die from it. Even giving them the wrong kind of testosterone in the wrong way did not cause any ill effects on prostate size, symptoms, or prostate specific antigen (PSA) level. “No significant side effects in prostate tests or symptoms were seen in this study.” They should have diagnosed them for the many other benefits of testosterone therapy. Acta Endocrinologica v.74, 1970 and v.80, 1973
|
